00546 FUFENG GROUP
- 4.750
- +0.130+2.81%
FUFENG GROUP News
Fufeng Group (0546.HK): Leading biofermentation in multiple categories ready to go
Fufeng Group (0546.HK): Profit attributable to 2024H1 shareholders decreased by 32.3% year on year. The company declared an interim dividend of HK18 cents per share
Fufeng Group (00546.HK): Year-on-year decline in monosodium glutamate and xanthan gum prices dragged down 1H24 performance
CICC: Maintains 'outperform' rating on Fufeng Group (00546), with target price lowered to HKD 5.3.
Fufeng Group (00546.HK): Profit attributable to shareholders fell 18.57% year-on-year in 2023. The company actively lays out overseas production bases
Fufeng Group (00546.HK): Performance is in line with expectations, high dividends drive value revaluation
Fufeng Group (0546.HK): Profit attributable to shareholders fell 24.10% year on year in 2023H1 and actively implemented the internationalization strategy
Fufeng Group (00546.HK): 1H23 performance is in line with expectations and awaits improvement in amino acid supply and demand
Fufeng Group (0546.HK): Profit attributable to shareholders increased by 201.5% year-on-year in 2022, benefiting from the boom in xanthan gum
Fufeng Group (0546.HK) handover coverage: Profit attributable to shareholders increased 201.5% year-on-year in 2022, benefiting from the high boom in xanthan gum
Fufeng Group (00546.HK): A sharp rise in volume and price, high growth in revenue and profit
Fufeng Group (00546.HK): Performance meets expectations, high dividends, shared growth
Fufeng Group (00546.HK): Steady revenue growth and sharp increase in profit
Fufeng Group (00546.HK): 1H22 performance exceeds expectations and plans to expand overseas production to enhance competitiveness
Fufeng Group (0546.HK): Shareholders should account for 2,026 million yuan of profit during the 2022 H1 period, an increase of 242.8% year-on-year, which is expected to benefit from the continuation of the high boom in xanthan gum
Fufeng Group (0546.HK): The year-on-year increase in net profit in 2022/H1 was more than 100% optimistic about the company's long-term performance growth
Fufeng Group (00546.HK): 1H21 performance is in line with expectations, waiting for demand to recover
Fufeng Group (00546.HK): Prices for various products such as monosodium glutamate and feed amino acids are rising, and the supply and demand pattern continues to improve
Fufeng Group (00546.HK): The results for the first half of the year are in line with expectations, and a moderate recovery in demand is expected to usher in a rebound in product prices
Fufeng Group (00546.HK): 2019 results are in line with expectations due to the impact of the epidemic, monosodium glutamate prices are under pressure in the short term
Analysis
Price Target
No Data
No Data